Giorgio Gandaglia
Vita-Salute San Raffaele University
DissectionInternal medicineRadiologyUrologySurgeryOncologyStage (cooking)Hazard ratioCystectomyBiopsyProstateBiochemical recurrenceProstatectomyProstate cancerBladder cancerLymph nodeIn patientProportional hazards modelRadiation therapyGeneral surgeryMedicineCohort
581Publications
47H-index
6,516Citations
Publications 594
Newest
#1Alberto MartiniH-Index: 27
#2G.O. CirulliH-Index: 3
Last. John P. SfakianosH-Index: 26
view all 15 authors...
Source
#1Elio MazzoneH-Index: 11
#2Giorgio GandagliaH-Index: 47
Last. R. Jeffrey KarnesH-Index: 70
view all 25 authors...
Source
#1Luigi NoceraH-Index: 5
Last. R. LeniH-Index: 1
view all 20 authors...
Source
#1Giorgio GandagliaH-Index: 47
#2Giuseppe RosielloH-Index: 9
Last. Andrea GallinaH-Index: 62
view all 16 authors...
Source
Source
#1Giorgio GandagliaH-Index: 47
#2Daniele RobestiH-Index: 7
Last. Andrea NecchiH-Index: 35
view all 13 authors...
Source
#1Giorgio GandagliaH-Index: 47
#2Daniele RobestiH-Index: 7
Last. R. LeniH-Index: 1
view all 14 authors...
Source
#1Luigi Nocera (UdeM: Université de Montréal)H-Index: 5
#2M. Wenzel (UdeM: Université de Montréal)
Last. Markus GraefenH-Index: 101
view all 0 authors...
BACKGROUND Race/ethnicity may predispose to less favorable prostate cancer characteristics in intermediate risk prostate cancer (IR PCa) patients. We tested this hypothesis in a subgroup of IR PCa patients treated with radical prostatectomy (RP). METHODS We relied on the Surveillance, Epidemiology and End Results 2004-2016. The effect of race/ethnicity was tested in univariable and multivariable logistic regression analyses predicting upstaging (pT3+/pN1) and/or upgrading (Gleason Grade Group [G...
Source
#1Elio Mazzone (UniSR: Vita-Salute San Raffaele University)H-Index: 11
#2Giorgio Gandaglia (UniSR: Vita-Salute San Raffaele University)H-Index: 47
Last. Marco MoschiniH-Index: 27
view all 0 authors...
Abstract null null Background null Despite the key importance of magnetic resonance imaging (MRI) parameters, risk classification systems for biochemical recurrence (BCR) in prostate cancer (PCa) patients treated with radical prostatectomy (RP) are still based on clinical variables alone. null null null Objective null We aimed at developing and validating a novel classification integrating clinical and radiological parameters. null null null Design, setting, and participants null A retrospective...
Source
#1Igor TsaurH-Index: 22
#2Isabel Heidegger (Innsbruck Medical University)H-Index: 21
Last. Eliott Debedde (Paris V: Paris Descartes University)
view all 24 authors...
BACKGROUND Docetaxel (D) or secondary hormonal therapy (SHT) each combined with androgen deprivation therapy (ADT) represent possible treatment options in males with metastasized hormone-sensitive prostate cancer (mHSPC). Real-world data comparing different protocols are lacking yet. Thus, our objective was to compare the efficacy and safety of abiraterone acetate (AA)+ADT versus D+ADT in mHSPC. METHODS In a retrospective multicenter analysis including males with mHSPC treated with either of the...
Source